- Home
- ERAS vs CHPT Comparison
ERAS vs CHPT Comparison
Compare ERAS & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CHPT
- Stock Information
- Founded
- ERAS 2018
- CHPT 2007
- Country
- ERAS United States
- CHPT United States
- Employees
- ERAS N/A
- CHPT N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CHPT Industrial Specialties
- Sector
- ERAS Health Care
- CHPT Consumer Discretionary
- Exchange
- ERAS Nasdaq
- CHPT Nasdaq
- Market Cap
- ERAS 396.6M
- CHPT 468.9M
- IPO Year
- ERAS 2021
- CHPT N/A
- Fundamental
- Price
- ERAS $1.43
- CHPT $0.61
- Analyst Decision
- ERAS Strong Buy
- CHPT Hold
- Analyst Count
- ERAS 6
- CHPT 10
- Target Price
- ERAS $4.83
- CHPT $1.58
- AVG Volume (30 Days)
- ERAS 1.5M
- CHPT 7.8M
- Earning Date
- ERAS 05-20-2025
- CHPT 06-04-2025
- Dividend Yield
- ERAS N/A
- CHPT N/A
- EPS Growth
- ERAS N/A
- CHPT N/A
- EPS
- ERAS N/A
- CHPT N/A
- Revenue
- ERAS N/A
- CHPT $417,083,000.00
- Revenue This Year
- ERAS N/A
- CHPT $12.03
- Revenue Next Year
- ERAS N/A
- CHPT $26.85
- P/E Ratio
- ERAS N/A
- CHPT N/A
- Revenue Growth
- ERAS N/A
- CHPT N/A
- 52 Week Low
- ERAS $1.01
- CHPT $0.51
- 52 Week High
- ERAS $3.45
- CHPT $2.44
- Technical
- Relative Strength Index (RSI)
- ERAS 52.92
- CHPT 48.51
- Support Level
- ERAS $1.37
- CHPT $0.61
- Resistance Level
- ERAS $1.61
- CHPT $0.63
- Average True Range (ATR)
- ERAS 0.14
- CHPT 0.03
- MACD
- ERAS 0.00
- CHPT 0.00
- Stochastic Oscillator
- ERAS 53.09
- CHPT 28.46
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CHPT ChargePoint Holdings Inc.
ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.